Thoracic Mobilization Versus Counterforce Forearm Brace in Treatment of Lateral Elbow Tendinopathy

NCT07113912 | Completed

• 1 other identifier: physio 7 2025
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

The study aim to compare the effect of thoracic mobilization versus counterforce forearm brace in treatment of LET. Detailed Description: Conditions: Lateral elbow tendinopathy Keywords: LET, Tennis elbow, Thoracic mobilization \& counterforce forearm brace.

Conditions

Lateral Elbow Tendinopathy

Outcome Measures

Primary Outcomes (1)

• Visual Analog Scale (VAS)

  consists of a 10 cm (or 100 mm) horizontal or vertical line, where 0 indicates no pain, and 10 (or 100 mm) represent the worst imaginable pain

  4 weeks

Study Arms (2)

Experimental group

EXPERIMENTAL

Received counterforce forearm brace and conventional therapy.

Device: counterforce forearm brace

Control group

ACTIVE COMPARATOR

Received thoracic mobilization and conventional therapy.

Procedure: thoracic immobilization

Interventions

counterforce forearm brace DEVICE

a flexible band that fits around the proximal forearm, applying pressure to underlying tissues during activity to potentially reduce acceleration forces and alleviate pain associated with conditions like lateral epicondylitis.

Experimental group

thoracic immobilization PROCEDURE

the methods and devices used to restrict movement of the thoracic spine, which is the upper and middle part of the back.

Control group

Eligibility Criteria

• Age: 18 Years - 55 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Patients clinically diagnosed as lateral elbow tendinopathy.
• Positive clinical sign on the following: Cozen's test Mill's test and Maudsley's test
• Pain involving in age group of 18-55 years
• Patients complaining from unilateral elbow pain, more than 3 months

You may not qualify if:

• Previous Surgery or Intervention (e.g., tendon release, debridement, or joint replacement) in the affected shoulder/elbow are excluded
• Presence of systemic conditions affecting tendon healing like rheumatoid arthritis, diabetes, or other systemic diseases that impair tendon healing or exacerbate pain can confound results
• Severe Comorbidities Such as Severe cardiovascular, neurological, or musculoskeletal disorders

Sponsors & Collaborators

• Deraya University: lead

Study Sites (1)

Deraya universuty

Minya, Egypt

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 3, 2025
• First Posted: August 11, 2025
• Study Start: March 25, 2025
• Primary Completion: May 10, 2025
• Study Completion: August 20, 2025
• Last Updated: September 23, 2025

Record last verified: 2025-09

Locations

EG (1)